Search research articles
Contact Us
Filters
Showing results (41-50 of 93) with videos related to
Page
of 10
Sort By:
JAMA Oncology
|
June 1, 2016
Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial
Saby George, Robert J Motzer, Hans J Hammers, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2020
Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability
Yuanquan Yang, Rohit K Jain, Sean T Glenn, et al.
The Prostate
|
December 20, 2016
Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer
Ajjai Alva, Luke Nordquist, Stephanie Daignault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2008
Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
Ali Reza Golshayan, Saby George, Daniel Y Heng, et al.
Journal of Cancer Epidemiology
|
January 11, 2017
Role of Private Enterprise in Cancer Control in Low to Middle Income Countries
Chukwumere E Nwogu, Martin Mahoney, Ifeoma Okoye, et al.
Urology
|
April 29, 2014
High-dose interleukin-2 therapy for metastatic renal cell carcinoma: a contemporary experience
Michael Hanzly, Ahmed Aboumohamed, Naveen Yarlagadda, et al.
Clinical Genitourinary Cancer
|
October 1, 2008
Phase I/II trial of 5-fluorouracil and a noncytotoxic dose level of suramin in patients with metastatic renal cell carcinoma
Saby George, Robert Dreicer, Jessie J L Au, et al.
The Lancet. Oncology
|
January 20, 2019
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial
David Cella, Viktor Grünwald, Bernard Escudier, et al.
Cancer
|
February 10, 2024
Safety and effectiveness of the radium-223-taxane treatment sequence in patients with metastatic castration-resistant prostate cancer in a global observational study (REASSURE)
Celestia S Higano, Sabina Dizdarevic, John Logue, et al.
Oncoimmunology
|
December 8, 2018
PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab
Saby George, Antonios Papanicolau-Sengos, Felicia L Lenzo, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 93) with videos related to
Sort By:
Page
of 10
JAMA Oncology
|
June 1, 2016
Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial
Saby George, Robert J Motzer, Hans J Hammers, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2020
Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability
Yuanquan Yang, Rohit K Jain, Sean T Glenn, et al.
The Prostate
|
December 20, 2016
Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer
Ajjai Alva, Luke Nordquist, Stephanie Daignault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2008
Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
Ali Reza Golshayan, Saby George, Daniel Y Heng, et al.
Journal of Cancer Epidemiology
|
January 11, 2017
Role of Private Enterprise in Cancer Control in Low to Middle Income Countries
Chukwumere E Nwogu, Martin Mahoney, Ifeoma Okoye, et al.
Urology
|
April 29, 2014
High-dose interleukin-2 therapy for metastatic renal cell carcinoma: a contemporary experience
Michael Hanzly, Ahmed Aboumohamed, Naveen Yarlagadda, et al.
Clinical Genitourinary Cancer
|
October 1, 2008
Phase I/II trial of 5-fluorouracil and a noncytotoxic dose level of suramin in patients with metastatic renal cell carcinoma
Saby George, Robert Dreicer, Jessie J L Au, et al.
The Lancet. Oncology
|
January 20, 2019
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial
David Cella, Viktor Grünwald, Bernard Escudier, et al.
Cancer
|
February 10, 2024
Safety and effectiveness of the radium-223-taxane treatment sequence in patients with metastatic castration-resistant prostate cancer in a global observational study (REASSURE)
Celestia S Higano, Sabina Dizdarevic, John Logue, et al.
Oncoimmunology
|
December 8, 2018
PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab
Saby George, Antonios Papanicolau-Sengos, Felicia L Lenzo, et al.
Page
of 10